Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Icahn Enterprises L.P is a conglomerates business based in the US. Icahn Enterprises L-P shares (IEP) are listed on the NASDAQ and all prices are listed in US Dollars. Icahn Enterprises L-P employs 23,833 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$50.00|
|52-week range||$41.67 - $62.09|
|50-day moving average||$54.32|
|200-day moving average||$56.46|
|Wall St. target price||$70.00|
|Dividend yield||$8 (15.9%)|
|Earnings per share (TTM)||$-2.24|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-2.34%|
|1 month (2021-08-26)||-7.39%|
|3 months (2021-06-25)||-10.68%|
|6 months (2021-03-26)||-8.64%|
|1 year (2020-09-25)||4.12%|
|2 years (2019-09-26)||-23.23%|
|3 years (2018-09-26)||69.11|
|5 years (2016-09-26)||0.79%|
Valuing Icahn Enterprises L-P stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Icahn Enterprises L-P's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Icahn Enterprises L-P's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $771 million.
The EBITDA is a measure of a Icahn Enterprises L-P's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$9.9 billion|
|Operating margin TTM||2.61%|
|Gross profit TTM||$-649,000,000|
|Return on assets TTM||0.61%|
|Return on equity TTM||-4.82%|
|Market capitalisation||$13.2 billion|
TTM: trailing 12 months
There are currently 200,687 Icahn Enterprises L-P shares held short by investors – that's known as Icahn Enterprises L-P's "short interest". This figure is 4% down from 209,065 last month.
There are a few different ways that this level of interest in shorting Icahn Enterprises L-P shares can be evaluated.
Icahn Enterprises L-P's "short interest ratio" (SIR) is the quantity of Icahn Enterprises L-P shares currently shorted divided by the average quantity of Icahn Enterprises L-P shares traded daily (recently around 282657.74647887). Icahn Enterprises L-P's SIR currently stands at 0.71. In other words for every 100,000 Icahn Enterprises L-P shares traded daily on the market, roughly 710 shares are currently held short.
However Icahn Enterprises L-P's short interest can also be evaluated against the total number of Icahn Enterprises L-P shares, or, against the total number of tradable Icahn Enterprises L-P shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Icahn Enterprises L-P's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Icahn Enterprises L-P shares in existence, roughly 0 shares are currently held short) or 0.0079% of the tradable shares (for every 100,000 tradable Icahn Enterprises L-P shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Icahn Enterprises L-P.
Find out more about how you can short Icahn Enterprises L-P stock.
We're not expecting Icahn Enterprises L-P to pay a dividend over the next 12 months.
Icahn Enterprises L-P's shares were split on a 10059:1000 basis on 12 November 2012. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 10059 shares. This wouldn't directly have changed the overall worth of your Icahn Enterprises L-P shares – just the quantity. However, indirectly, the new 90.1% lower share price could have impacted the market appetite for Icahn Enterprises L-P shares which in turn could have impacted Icahn Enterprises L-P's share price.
Over the last 12 months, Icahn Enterprises L-P's shares have ranged in value from as little as $41.6744 up to $62.0903. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Icahn Enterprises L-P's is 0.9045. This would suggest that Icahn Enterprises L-P's shares are less volatile than average (for this exchange).
Icahn Enterprises L. P. , through its subsidiaries, operates in investment, energy, automotive, food packaging, metals, real estate, home fashion, and pharma businesses in the United States and Internationally. The company's Investment segment invests its proprietary capital through various private investment funds. Its Energy segment refines and markets transportation fuels; and produces and markets nitrogen fertilizers in the form of urea ammonium nitrate and ammonia. The company's Automotive segment is involved in the retail and wholesale distribution of automotive parts; and offers automotive repair and maintenance services. This segment also purchases and leases vehicles.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.